Literature DB >> 22179784

Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes.

L Patrucco1, J I Rojas, E Cristiano.   

Abstract

The purpose of this study was to determine the value of spinal cord lesions as a predictive factor for conversion in clinically isolated syndrome (CIS) patients. Patients with CIS and without immunomodulatory treatment were prospectively included. Age at onset, sex, clinical syndrome at onset, oligoclonal bands, and presence, number and location of lesions on brain and spinal MRI were analyzed. Conversion to multiple sclerosis (MS) was the primary endpoint. Cox regression was used to compare outcomes between groups. A total of 75 patients were included: 53 (71%) women, mean age at onset 32.7 years (SD ± 7.5), mean follow-up time 72.5 months (SD ± 9; range 17-104 months). There were 11 (14.6%) patients with one focal spinal cord lesion, while 13 (17%) patients had two or more spinal cord lesions at the first scan during the onset of the disease. Of the 23 patients (30.6%) who converted to clinically definite MS (CDMS), 2 had a normal spinal cord MRI, 8 patients had one spinal cord lesion, and 13 had more than one lesion on MRI (p < 0.001). In multivariable analyses, one focal spinal cord lesion was significantly associated with increased risk of conversion to MS (p = 0.01, HR 3.5, CI 95% 2.1-6.9), while the presence of two or more focal spinal cord lesions was independently associated with a higher risk of conversion to MS (p < 0.001, HR 5.9, CI 95% 3.2-10.8). CIS patients with an abnormal baseline spinal cord MRI have a higher risk for developing clinically definite MS, independent of brain lesions as well as the presence of cerebrospinal fluid oligoclonal banding (OSF-OB) .

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179784     DOI: 10.1007/s00415-011-6345-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  Anaphylaxis to sesame.

Authors:  G B Pajno; G Passalacqua; G Magazzu; G Barberio; D Vita; G W Canonica
Journal:  Allergy       Date:  2000-02       Impact factor: 13.146

Review 2.  Environmental factors and multiple sclerosis.

Authors:  George C Ebers
Journal:  Lancet Neurol       Date:  2008-03       Impact factor: 44.182

3.  Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.

Authors:  J Masjuan; J C Alvarez-Cermeño; N García-Barragán; M Díaz-Sánchez; M Espiño; M C Sádaba; P González-Porqué; J Martínez San Millán; L M Villar
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

4.  Is optic neuritis more benign than other first attacks in multiple sclerosis?

Authors:  Mar Tintoré; Alex Rovira; Jordi Rio; Carlos Nos; Elisensa Grivé; Neus Téllez; Raul Pelayo; Manuel Comabella; Xavier Montalban
Journal:  Ann Neurol       Date:  2005-02       Impact factor: 10.422

5.  Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

Authors:  M Tintoré; A Rovira; J Río; C Nos; E Grivé; N Téllez; R Pelayo; M Comabella; J Sastre-Garriga; X Montalban
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

Review 6.  Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

Authors:  M Clerico; F Faggiano; J Palace; G Rice; M Tintorè; L Durelli
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 7.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

8.  Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Authors:  M Tintoré; A Rovira; J Río; C Tur; R Pelayo; C Nos; N Téllez; H Perkal; M Comabella; J Sastre-Garriga; X Montalban
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

9.  Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study.

Authors:  Ludwig Kappos; Mark S Freedman; Chris H Polman; Gilles Edan; Hans-Peter Hartung; David H Miller; Xavier Montalbán; Frederik Barkhof; Ernst-Wilhelm Radü; Lars Bauer; Susanne Dahms; Vivian Lanius; Christoph Pohl; Rupert Sandbrink
Journal:  Lancet       Date:  2007-08-04       Impact factor: 79.321

Review 10.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

View more
  11 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Thoracic spinal cord lesions are influenced by the degree of cervical spine involvement in multiple sclerosis.

Authors:  L H Hua; S L Donlon; M J Sobhanian; S M Portner; D T Okuda
Journal:  Spinal Cord       Date:  2015-01-13       Impact factor: 2.772

3.  Criteria improving multiple sclerosis diagnosis at the first MRI.

Authors:  Nathalie Caucheteux; Adil Maarouf; Margaux Genevray; Emmanuelle Leray; Romain Deschamps; Marie P Chaunu; Laure Daelman; Jean C Ferré; Olivier Gout; Jean Pelletier; Laurent Pierot; Gilles Edan; Ayman Tourbah
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

Review 4.  Radiologically isolated syndrome: from biological bases to practical management.

Authors:  Andres G Barboza; Edgar Carnero Contentti; Maria Celeste Curbelo; Mario Javier Halfon; Juan Ignacio Rojas; Berenice A Silva; Vladimiro Sinay; Santiago Tizio; Maria Celica Ysrraelit; Ricardo Alonso
Journal:  Neurol Sci       Date:  2021-01-25       Impact factor: 3.307

5.  Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.

Authors:  Adrienne N Dula; Siddharama Pawate; Richard D Dortch; Robert L Barry; Kristen M George-Durrett; Bailey D Lyttle; Lindsey M Dethrage; John C Gore; Seth A Smith
Journal:  Mult Scler       Date:  2015-07-24       Impact factor: 6.312

6.  Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.

Authors:  A J Ligocki; W H Rounds; E M Cameron; C T Harp; E M Frohman; A M Courtney; S Vernino; L G Cowell; B Greenberg; N L Monson
Journal:  Genes Immun       Date:  2013-04-18       Impact factor: 2.676

Review 7.  Multiple sclerosis imaging: recent advances.

Authors:  Maria A Rocca; Roberta Messina; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-21       Impact factor: 4.849

8.  Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?

Authors:  Raed Alroughani; Saeed Akhtar; Samar Ahmed; Raed Behbehani; Jasem Al-Hashel
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

9.  Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.

Authors:  Johanna Oechtering; Therese Lincke; Sabine Schaedelin; Bernhard F Décard; Aleksandra Maceski; Annette Orleth; Stephanie Meier; Eline Willemse; Arabella Buchmann; Michael Khalil; Tobias Derfuss; Pascal Benkert; Ingmar Heijnen; Axel Regeniter; Stefanie Müller; Lutz Achtnichts; Patrice Lalive; Anke Salmen; Caroline Pot; Claudio Gobbi; Ludwig Kappos; Cristina Granziera; David Leppert; Regina Schlaeger; Johanna M Lieb; Jens Kuhle
Journal:  Ann Neurol       Date:  2022-04-09       Impact factor: 11.274

10.  Evaluating single-point quantitative magnetization transfer in the cervical spinal cord: Application to multiple sclerosis.

Authors:  Alex K Smith; Samantha By; Bailey D Lyttle; Richard D Dortch; Bailey A Box; Lydia J Mckeithan; Saakshi Thukral; Francesca Bagnato; Siddharama Pawate; Seth A Smith
Journal:  Neuroimage Clin       Date:  2017-07-14       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.